ESTA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Establishment Labs Holdings Inc (ESTA) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows strong growth potential, supported by bullish analyst ratings, positive technical indicators, and a promising FDA label expansion catalyst. Despite recent financial losses, the company's revenue growth and gross margin improvements indicate long-term viability.
The technical indicators are bullish. The MACD is positive and contracting, RSI is neutral at 72.229, and moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 75.587), with further resistance at 78.025, suggesting potential for upward movement.
FDA label expansion application for Motiva breast reconstruction, which could drive future revenue growth.
Strong analyst sentiment with multiple price target increases (up to $
and reiterated Buy ratings.
Revenue growth of 33.70% YoY in Q3 2025, with gross margin improvement to 70.09%.
Hedge funds are selling, with a 348.78% increase in selling activity over the last quarter.
Net income and EPS have declined significantly YoY (-33.19% and -35.59%, respectively).
No recent congress trading data or influential figure activity to support sentiment.
In Q3 2025, revenue increased by 33.70% YoY to $53.78M, and gross margin improved to 70.09%. However, net income dropped by -33.19% to -$11.15M, and EPS declined by -35.59% to -0.38. These mixed results highlight strong revenue growth but ongoing profitability challenges.
Analysts are bullish on ESTA, with multiple firms raising price targets (up to $90) and maintaining Buy ratings. Analysts highlight strong growth drivers, including US breast augmentation and reconstruction markets, as well as the company's ability to sustain double-digit growth over the next five years.
